Entero Therapeutics announces 1-for-3 reverse stock split to regain Nasdaq compliance

GridAI Technologies Corp.

Reverse stock split at ratio 1-for-3 effective 12:01 a.m. ET on August 18, 2025.
Outstanding shares reduce from ~4.77 million to ~1.59 million; no fractional shares issued.
Split intended to raise bid price above $1.00 to satisfy Nasdaq Listing Rule 5550(a)(2).
Trading symbol remains ENTO; new CUSIP is 33749P507.
Interim CEO Richard Paolone states split is necessary to maintain Nasdaq listing.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

GridAI Technologies Corp.: Amended certificate of incorporation to effect a 1-for-3 reverse stock split (effective 2025-08-18).

Change: charter amendment
Effective: 2025-08-18

Exact text from the filing

On August 14, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

View on SEC.gov

74 governance changes filed in the last 30 days. Browse all governance changes →

GridAI Technologies Corp. filing history →

Source: SEC EDGAR

accession 0001104659-25-079322

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.